Consistent survival benefit of enzalutamide plus androgen deprivation therapy in men with nonmetastatic castration-resistant prostate cancer: PROSPER subgroup analysis by age and region
Titel:
Consistent survival benefit of enzalutamide plus androgen deprivation therapy in men with nonmetastatic castration-resistant prostate cancer: PROSPER subgroup analysis by age and region
Auteur:
De Giorgi, Ugo Hussain, Maha Shore, Neal Fizazi, Karim Tombal, Bertrand Penson, David Saad, Fred Efstathiou, Eleni Madziarska, Katarzyna Steinberg, Joyce Sugg, Jennifer Lin, Xun Shen, Qi Sternberg, Cora N.